Blau Farmacêutica S.A. (BLAU3.SA)
BRL 12.57
(-5.42%)
BRL 12.57
(-5.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 188.06 Million | 171.9 Million | 153.97 Million | 226.51 Million | 221.29 Million | 82.53 Million |
| Net Income | 249.8 Million | 468.56 Million | 482.46 Million | 353.64 Million | 286.36 Million | 178.4 Million |
| Depreciation & Amortization | 38.88 Million | 22.28 Million | 20.91 Million | 17.17 Million | 9.92 Million | 10.24 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.16 Million | -237.06 Million | -197.15 Million | -95.1 Million | -39.54 Million | -92.58 Million |
| Other non-cash items | -95.46 Million | -81.87 Million | -152.25 Million | -49.19 Million | -35.45 Million | -13.52 Million |
| Investing Cash Flow | -356.77 Million | 132.96 Million | -870.32 Million | -220.78 Million | -146.62 Million | -153.24 Million |
| Investments in PPE | -264.39 Million | -180.13 Million | -177.77 Million | -91.2 Million | -13.46 Million | -251 Thousand |
| Acquisitions | -136.6 Million | - | - | -58.71 Million | - | -4.36 Million |
| Investment purchases | -265.15 Million | - | -692.53 Million | 91.2 Million | -50.78 Million | -97.85 Million |
| Sales/Maturities of investments | 309.37 Million | 313.09 Million | - | 8.49 Million | - | 251 Thousand |
| Other Investing Activities | -1.00 | -142.66 Million | -14 Thousand | -170.55 Million | -82.38 Million | -51.02 Million |
| Financing Cash Flow | 186.09 Million | -342.61 Million | 698.01 Million | 57.25 Million | -75.71 Million | 74.22 Million |
| Debt repayment | -277.49 Million | -121.88 Million | -516.01 Million | -105.36 Million | -48.47 Million | -104.86 Million |
| Dividends payments | -66.16 Million | -135.52 Million | -104.13 Million | -326.92 Million | -117.76 Million | -33.37 Million |
| Common Stock Repurchased | -2.99 Million | -80.74 Million | -26.02 Million | -10 Million | - | - |
| Common Stock Issuance | -14.84 Million | -40.85 Million | 1.21 Billion | - | - | - |
| Other Financing Activities | 547.59 Million | 36.39 Million | 128.22 Million | 499.54 Million | 90.52 Million | 212.45 Million |
| Accounts receivables | -11.15 Million | -125.18 Million | -107.92 Million | -130.56 Million | 7.47 Million | -75.64 Million |
| Accounts payables | -13.56 Million | 46.62 Million | -18.98 Million | 55.03 Million | -1.14 Million | 10.29 Million |
| Inventory | 24.72 Million | -160.39 Million | -93.62 Million | -148 Million | -48.37 Million | -27.04 Million |
| Other working capital | -5.18 Million | 1.89 Million | 23.38 Million | 128.43 Million | 2.49 Million | -65.53 Million |
| Cash at beginning of period | 14.11 Million | 51.86 Million | 70.19 Million | 6.41 Million | 11.07 Million | 9.16 Million |
| Cash at end of period | 31.49 Million | 14.11 Million | 51.86 Million | 70.19 Million | 6.41 Million | 11.07 Million |
| Capital Expenditure | -264.39 Million | -180.13 Million | -177.77 Million | -91.2 Million | -13.46 Million | -251 Thousand |
| Effect of forex changes on cash | - | - | - | 789 Thousand | -3.61 Million | -1.58 Million |
| Net cash flow / Change in cash | 17.38 Million | -37.75 Million | -18.33 Million | 63.78 Million | -4.66 Million | 1.91 Million |
| Free Cash Flow | -76.33 Million | -8.23 Million | -23.79 Million | 135.31 Million | 207.82 Million | 82.28 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 48.73 Million | 40.09 Million | 27.67 Million | 249.8 Million | 149.76 Million | 86.84 Million |
| Depreciation & Amortization | 7.8 Million | 12.01 Million | 12.51 Million | 38.88 Million | 11.61 Million | 7.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -31.59 Million | 27.54 Million | -14.28 Million | -5.16 Million | 4.18 Million | 17.55 Million |
| Other non-cash items | 85.92 Million | 28.65 Million | -41.52 Million | -95.46 Million | -104.48 Million | 14.47 Million |
| Investing Cash Flow | -2.07 Million | -70.53 Million | 43.02 Million | -356.77 Million | -462.09 Million | 67.67 Million |
| Investments in PPE | -69.01 Million | -46.77 Million | -58.96 Million | -264.39 Million | -60.85 Million | -96.47 Million |
| Acquisitions | - | - | -611 Thousand | -136.6 Million | -135.99 Million | 136.56 Million |
| Investment purchases | 23.76 Million | -23.76 Million | - | -265.15 Million | -128.58 Million | -136.56 Million |
| Sales/Maturities of investments | 43.18 Million | - | 102.6 Million | 309.37 Million | -136.66 Million | 300.71 Million |
| Other Investing Activities | 22.39 Million | -28.86 Million | - | -1.00 | - | -136.56 Million |
| Financing Cash Flow | -72.7 Million | -1.6 Million | -26.25 Million | 186.09 Million | 333.86 Million | -120.73 Million |
| Debt repayment | -50 Million | - | -3.6 Million | -277.49 Million | -3.6 Million | -61.25 Million |
| Dividends payments | -19.16 Million | - | -27.36 Million | -66.16 Million | -10.66 Million | -28.12 Million |
| Common Stock Repurchased | -1.79 Million | - | -2.45 Million | -2.99 Million | - | -11.71 Million |
| Common Stock Issuance | - | - | -14.84 Million | -14.84 Million | - | 28.12 Million |
| Other Financing Activities | -1.79 Million | - | 22.01 Million | 547.59 Million | 348.13 Million | -47.76 Million |
| Accounts receivables | -66.83 Million | -22.13 Million | -12.86 Million | -11.15 Million | -28.04 Million | -28.99 Million |
| Accounts payables | -57.48 Million | 22.48 Million | -16.29 Million | -13.56 Million | 5.8 Million | 20.17 Million |
| Inventory | 97.77 Million | -17.48 Million | 44.12 Million | 24.72 Million | -1.69 Million | 19.93 Million |
| Other working capital | -5.05 Million | 44.68 Million | -29.24 Million | -5.18 Million | 28.11 Million | 6.43 Million |
| Cash at beginning of period | 26.49 Million | 31.49 Million | 30.34 Million | 14.11 Million | 97.49 Million | 23.77 Million |
| Cash at end of period | 20.42 Million | 26.49 Million | 31.49 Million | 31.49 Million | 30.34 Million | 97.49 Million |
| Capital Expenditure | -69.01 Million | -46.77 Million | -58.96 Million | -264.39 Million | -60.85 Million | -96.47 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.06 Million | -5 Million | 1.15 Million | 17.38 Million | -67.15 Million | 73.72 Million |
| Free Cash Flow | -304 Thousand | 20.36 Million | -74.59 Million | -76.33 Million | 224 Thousand | 30.3 Million |
SHV
023800
BG
600773
BEEN
HGINFRA